These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14739052)

  • 21. Risk factor and cost accounting analysis for dialysis patients in Taiwan.
    Su BG; Tsai KL; Yeh SH; Ho YY; Liu SY; Rivers PA
    Health Serv Manage Res; 2010 May; 23(2):84-93. PubMed ID: 20424276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare costs associated with progressive diabetic retinopathy among National Health Insurance enrollees in Taiwan, 2000-2004.
    Woung LC; Tsai CY; Chou HK; Tsai MT; Tsai WH; Chou P; Shen ST
    BMC Health Serv Res; 2010 May; 10():136. PubMed ID: 20500894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of hospitalization and healthcare cost associated with Diabetes Complication Severity Index in Taiwan's National Health Insurance Research Database.
    Chen HL; Hsiao FY
    J Diabetes Complications; 2014; 28(5):612-6. PubMed ID: 25037987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
    Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life.
    Obi EN; Swindle JP; Turner SJ; Russo PA; Altan A
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1446-1456. PubMed ID: 27882835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012.
    Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
    Clin Ther; 2016 Jun; 38(6):1314-1326. PubMed ID: 27129399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic Costs of Diabetes in the U.S. in 2017.
    American Diabetes Association
    Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and lessons learned from evaluating TRICARE's disease management programs.
    Dall TM; Askarinam Wagner RC; Zhang Y; Yang W; Arday DR; Gantt CJ
    Am J Manag Care; 2010 Jun; 16(6):438-46. PubMed ID: 20560687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach.
    de Lagasnerie G; Aguadé AS; Denis P; Fagot-Campagna A; Gastaldi-Menager C
    Eur J Health Econ; 2018 Mar; 19(2):189-201. PubMed ID: 28190188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive healthcare resource use among newly diagnosed congestive heart failure.
    Bash LD; Weitzman D; Blaustein RO; Sharon O; Shalev V; Chodick G
    Isr J Health Policy Res; 2017; 6():26. PubMed ID: 28593038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of outpatient care utilization by seniors under the National Health Insurance in Taiwan.
    Hsu WC; Hsu YP
    J Formos Med Assoc; 2016 May; 115(5):325-34. PubMed ID: 26809492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting hospital fraud and claim abuse through diabetic outpatient services.
    Liou FM; Tang YC; Chen JY
    Health Care Manag Sci; 2008 Dec; 11(4):353-8. PubMed ID: 18998594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals.
    Chaikledkaew U; Pongchareonsuk P; Chaiyakunapruk N; Ongphiphadhanakul B
    Value Health; 2008 Mar; 11 Suppl 1():S69-74. PubMed ID: 18387070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of cognitive enhancers and associated medical care costs among patients with dementia: a nationwide study in Taiwan.
    Ku LJ; Pai MC
    Int Psychogeriatr; 2014 May; 26(5):795-804. PubMed ID: 24429098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in drug prescription utilization for diabetic and hypertensive outpatients after initiation of the National Health Insurance's Global Budget Program in Taiwan.
    Chou CC; Hu KY; Wu NR; Cheng YH; Loh CH; Yeh MK
    Med Sci Monit; 2008 May; 14(5):PH33-39. PubMed ID: 18443560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between diabetes and medical and dental care costs: findings from a worksite cohort study in Japan.
    Ide R; Hoshuyama T; Wilson DJ; Takahashi K; Higashi T
    Ind Health; 2010; 48(6):857-63. PubMed ID: 20616460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic peripheral neuropathy: resource utilization and burden of illness.
    Mehra M; Merchant S; Gupta S; Potluri RC
    J Med Econ; 2014 Sep; 17(9):637-45. PubMed ID: 24888404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes.
    Currie CJ; Morgan CL; Peters JR
    Diabetes Care; 1998 Jan; 21(1):42-8. PubMed ID: 9538969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications.
    Zhuo X; Zhang P; Hoerger TJ
    Am J Prev Med; 2013 Sep; 45(3):253-61. PubMed ID: 23953350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities.
    Zhao Y; Ye W; Boye KS; Holcombe JH; Swindle R
    Diabet Med; 2009 Jan; 26(1):61-9. PubMed ID: 19125762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.